3rd Quarter - Report

CSL BEHRING LLC for CSL BEHRING LLC

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages. Education on tax policies specific to the biopharmaceutical industry.

Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.

LobbyistCovered position, as disclosed
COLLEEN MALONEY —
MARY LACEY REUTHER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6465 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.